Showing results (311-320 of 393) with videos related to
Sort By:
Pageof 40
Psycho-Oncology|February 17, 2024
Pain coping, multidisciplinary care, and mHealth: Patients' views on managing advanced cancer painSara M DeForge, Kyla Smith, Kris-Ann Anderson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancerJeffrey A Meyerhardt, Andrew X Zhu, Peter C Enzinger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumorsMatthew H Kulke, Jason L Hornick, Christine Frauenhoffer, et al.Neuroimage|July 26, 2003
Experimental model for functional magnetic resonance imaging of somatic sensory cortex in the unanesthetized ratRobert N S Sachdev, Greg C Champney, Haakil Lee, et al.European Journal of Neurology|March 21, 2020
Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of NeurologyM Mancuso, M Arnold, A Bersano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancerMatthew H Kulke, Lawrence S Blaszkowsky, David P Ryan, et al.Journal of Palliative Medicine|April 8, 2017
Seeking and Accepting: U.S. Clergy Theological and Moral Perspectives Informing Decision Making at the End of LifeJustin J Sanders, Vinca Chow, Andrea C Enzinger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2012
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumorsJennifer A Chan, Keith Stuart, Craig C Earle, et al.Cancer|October 13, 2006
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumorsDavid P Ryan, Leonard J Appleman, Thomas Lynch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancerBrian M Wolpin, Aram F Hezel, Thomas Abrams, et al.Pageof 40